Trials / Active Not Recruiting
Active Not RecruitingNCT04325217
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 586 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective is to confirm the incidence of adverse drug reactions (focus on gastrointestinal symptoms including diarrhoea and nausea) to Ofev Capsules seen in clinical trials with real world data generated in patients with SSc-ILD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nintedanib | Capsules |
Timeline
- Start date
- 2020-05-27
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2020-03-27
- Last updated
- 2026-03-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04325217. Inclusion in this directory is not an endorsement.